Cargando…

Assessment of a novel, capsid-modified adenovirus with an improved vascular gene transfer profile

BACKGROUND: Cardiovascular disorders, including coronary artery bypass graft failure and in-stent restenosis remain significant opportunities for the advancement of novel therapeutics that target neointimal hyperplasia, a characteristic of both pathologies. Gene therapy may provide a successful appr...

Descripción completa

Detalles Bibliográficos
Autores principales:	White, Katie M, Alba, Raul, Parker, Alan L, Wright, Audrey F, Bradshaw, Angela C, Delles, Christian, McDonald, Robert A, Baker, Andrew H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751082/ https://www.ncbi.nlm.nih.gov/pubmed/23937994 http://dx.doi.org/10.1186/1749-8090-8-183

Ejemplares similares

Efficient Transduction of Primary Vascular Cells by the Rare Adenovirus Serotype 49 Vector
por: Dakin, Rachel S., et al.
Publicado: (2015)

Pseudotyping the adenovirus serotype 5 capsid with both the fibre and penton of serotype 35 enhances vascular smooth muscle cell transduction
por: Parker, A L, et al.
Publicado: (2013)

Biodistribution and inflammatory profiles of novel penton and hexon double-mutant serotype 5 adenoviruses
por: Bradshaw, Angela C., et al.
Publicado: (2012)

Defining a Novel Role for the Coxsackievirus and Adenovirus Receptor in Human Adenovirus Serotype 5 Transduction In Vitro in the Presence of Mouse Serum
por: Lopez-Gordo, Estrella, et al.
Publicado: (2017)

Evaluation of adenovirus capsid labeling versus transgene expression
por: Li, Jing, et al.
Publicado: (2010)

CryoEM Visualization of an Adenovirus Capsid-Incorporated HIV Antigen
por: Flatt, Justin W., et al.
Publicado: (2012)

Optimization of capsid-incorporated antigens for a novel adenovirus vaccine approach
por: Matthews, Qiana L, et al.
Publicado: (2008)

Viral Capsid Is a Pathogen-Associated Molecular Pattern in Adenovirus Keratitis
por: Chintakuntlawar, Ashish V., et al.
Publicado: (2010)

A Capsid-Encoded PPxY-Motif Facilitates Adenovirus Entry
por: Wodrich, Harald, et al.
Publicado: (2010)

Insight into the Mechanisms of Adenovirus Capsid Disassembly from Studies of Defensin Neutralization
por: Smith, Jason G., et al.
Publicado: (2010)

A novel capsid-modified oncolytic recombinant adenovirus type 5 for tumor-targeting gene therapy by intravenous route
por: Wang, Zhen, et al.
Publicado: (2016)

Requirements for Receptor Engagement during Infection by Adenovirus Complexed with Blood Coagulation Factor X
por: Bradshaw, Angela C., et al.
Publicado: (2010)

In Vitro and In Vivo Evaluation of Human Adenovirus Type 49 as a Vector for Therapeutic Applications
por: Bates, Emily A., et al.
Publicado: (2021)

Critical Role of Autophagy in the Processing of Adenovirus Capsid-Incorporated Cancer-Specific Antigens
por: Klein, Sarah R., et al.
Publicado: (2016)

Genetic and Chemical Capsid Modifications of Adenovirus Vectors to Modulate Vector–Host Interactions
por: Weklak, Denice, et al.
Publicado: (2021)

Efficient gene transfer into T lymphocytes by fiber-modified human adenovirus 5
por: Lv, Yun, et al.
Publicado: (2019)

Designer Oncolytic Adenovirus: Coming of Age
por: Baker, Alexander T., et al.
Publicado: (2018)

Modular capsid decoration boosts adenovirus vaccine-induced humoral immunity against SARS-CoV-2
por: Dicks, Matthew D.J., et al.
Publicado: (2022)

An Intrinsically Disordered Region of the Adenovirus Capsid Is Implicated in Neutralization by Human Alpha Defensin 5
por: Flatt, Justin W., et al.
Publicado: (2013)

A tropism-transformed Oncolytic Adenovirus with Dual Capsid Modifications for enhanced Glioblastoma Therapy
por: Wang, Lizheng, et al.
Publicado: (2020)

Refined Capsid Structure of Human Adenovirus D26 at 3.4 Å Resolution
por: Reddy, Vijay S., et al.
Publicado: (2022)

Understanding Post Entry Sorting of Adenovirus Capsids; A Chance to Change Vaccine Vector Properties
por: Daussy, Coralie F., et al.
Publicado: (2021)

Adenovirus core protein V reinforces the capsid and enhances genome release from disrupted particles
por: Martín-González, Natalia, et al.
Publicado: (2023)

Adenovirus-Derived Nano-Capsid Platforms for Targeted Delivery and Penetration of Macromolecules into Resistant and Metastatic Tumors
por: Benhaghnazar, Rebecca Leah, et al.
Publicado: (2023)

Substantial Dysregulation of miRNA Passenger Strands Underlies the Vascular Response to Injury
por: Pinel, Karine, et al.
Publicado: (2019)

Nanomedicine and Phage Capsids
por: Serwer, Philip, et al.
Publicado: (2018)

The Role of the Adeno-Associated Virus Capsid in Gene Transfer
por: Van Vliet, Kim M., et al.
Publicado: (2008)

Covalent decoration of adenovirus vector capsids with the carbohydrate epitope αGal does not improve vector immunogenicity, but allows to study the in vivo fate of adenovirus immunocomplexes
por: Kratzer, Ramona F., et al.
Publicado: (2017)

CRM1 Promotes Capsid Disassembly and Nuclear Envelope Translocation of Adenovirus Independently of Its Export Function
por: Lagadec, Floriane, et al.
Publicado: (2022)

Tropism-Modification Strategies for Targeted Gene Delivery Using Adenoviral Vectors
por: Coughlan, Lynda, et al.
Publicado: (2010)

Antigen capsid-display on human adenovirus 35 via pIX fusion is a potent vaccine platform
por: Salisch, Nadine C., et al.
Publicado: (2017)

Adenovirus major core protein condenses DNA in clusters and bundles, modulating genome release and capsid internal pressure
por: Martín-González, Natalia, et al.
Publicado: (2019)

HIV Capsid and Integration Targeting
por: Engelman, Alan N.
Publicado: (2021)

Adenovirus-Vectored Capsid Proteins of the Serotype A Foot-and-Mouth Disease Virus Protect Guinea Pigs Against Challenge
por: Xie, Yinli, et al.
Publicado: (2020)

Human species D adenovirus hexon capsid protein mediates cell entry through a direct interaction with CD46
por: Persson, B. David, et al.
Publicado: (2021)

Vascular biomedicine in an era of chronic disease and multimorbidity
por: Currie, Gemma, et al.
Publicado: (2019)

Microglia-specific targeting by novel capsid-modified AAV6 vectors
por: Rosario, Awilda M, et al.
Publicado: (2016)

Modifying immune responses to adeno-associated virus vectors by capsid engineering
por: Bentler, Martin, et al.
Publicado: (2023)

Retargeting FX-binding-ablated HAdV-5 to vascular cells by inclusion of the RGD-4C peptide in hexon hypervariable region 7 and the HI loop
por: Robertson, Stacy, et al.
Publicado: (2016)

Adenoviruses Using the Cancer Marker EphA2 as a Receptor In Vitro and In Vivo by Genetic Ligand Insertion into Different Capsid Scaffolds
por: Behr, Michael, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ch26l9ah919dpdlijepf4u9l25